Tracking germs that resist key antibiotics in Swiss hospitals
Part of Infections clinical trials.
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a lab test in a Swiss tertiary care hospital that found carbapenemase-producing bacteria
- The detection happened between January 1, 2008 and December 31, 2028
- Your medical team is using your collected hospital data for this study
- You did not officially refuse the later use of your data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a Swiss database using lab genetic testing (whole genome sequencing) plus basic patient information to track outbreaks of serious, drug-resistant, and sometimes high-infectious pathogens. Your data could help researchers understand how these germs spread and how to better prevent them.
This study looks at whether certain bacteria that carry ESBL enzymes are spreading between people. To join, you would need lab-confirmed evidence that you carry these bacteria based on routine samples taken during usual care.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study looks at hospital wastewater to predict outbreaks of antibiotic-resistant bacteria. To take part, you must have a confirmed infection from such bacteria while in one of four specific hospital areas.
This study looks at whether a rapid test can help doctors detect CPE bacteria (which are resistant to many antibiotics) sooner, and whether using infection control measures can stop these bacteria from spreading. It may help you get the right care and reduce the risk of infection while in the hospital.
Hear when a new Infections With CPB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.